Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asahi Ito

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Cancer Science|October 29, 2017
Clinical significance of tryptophan catabolism in Hodgkin lymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Cancer Science|June 28, 2012
Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphomaSusumu Suzuki, Ayako Masaki, Takashi Ishida, et al.
International Journal of Hematology|May 23, 2019
Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myelomaReham Ashour, Masaki Ri, Sanaa Shaker Aly, et al.
Hematological Oncology|August 31, 2022
CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatmentYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
European Journal of Haematology|November 6, 2013
Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse modelFumiko Mori, Takashi Ishida, Asahi Ito, et al.
International Journal of Hematology|November 25, 2024
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Blood|June 25, 2017
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphomaTomoko Narita, Takashi Ishida, Asahi Ito, et al.
Ejhaem|July 18, 2022
Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational studyTakafumi Nakayama, Yoshiko Oshima, Shigeru Kusumoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/LymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2015
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Cancer Science|October 29, 2017
Clinical significance of tryptophan catabolism in Hodgkin lymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Cancer Science|June 28, 2012
Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphomaSusumu Suzuki, Ayako Masaki, Takashi Ishida, et al.
International Journal of Hematology|May 23, 2019
Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myelomaReham Ashour, Masaki Ri, Sanaa Shaker Aly, et al.
Hematological Oncology|August 31, 2022
CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatmentYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
European Journal of Haematology|November 6, 2013
Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse modelFumiko Mori, Takashi Ishida, Asahi Ito, et al.
International Journal of Hematology|November 25, 2024
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Blood|June 25, 2017
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphomaTomoko Narita, Takashi Ishida, Asahi Ito, et al.
Ejhaem|July 18, 2022
Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational studyTakafumi Nakayama, Yoshiko Oshima, Shigeru Kusumoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/LymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2015
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Pageof 7